Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Ratings

Analyst Ratings

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Upgrades

Alembic Global Upgrades AeroVironment to Overweight

By Benzinga Newsdesk
July 1, 1:48 PM
Alembic Global analyst Peter Skibitski upgrades AeroVironment (NASDAQ:AVAV) from Neutral to Overweight.

AVAV

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Maxim Group Downgrades 9 Meters Biopharma to Hold

By Benzinga Newsdesk
July 1, 1:47 PM
Maxim Group analyst Jason McCarthy downgrades 9 Meters Biopharma (NASDAQ:NMTR) from Buy to Hold.

NMTR

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Alliance Global Partners Downgrades Neptune Wellness Solns to Neutral

By Benzinga Newsdesk
July 1, 1:45 PM
Alliance Global Partners analyst Aaron Grey downgrades Neptune Wellness Solns (NASDAQ:NEPT) from Buy to Neutral.

NEPT

Read More
1 minute read
  • Analyst Ratings
  • News
  • Tech

Here’s How Credit Suisse Views May EV Performance

By Anusuya Lahiri
July 1, 12:55 PM
Credit Suisse analyst Dan Levy shared vital takeaways from May EV sales. Global EV penetration was 13% in May, up ~150bp M/M, above the YTD '22 pace and well ahead of the 2021 EV penetration rate.

LI

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Mizuho Slashes Price Targets Of Mastercard, Visa Out Of Precaution – Read Why

By Anusuya Lahiri
July 1, 12:52 PM
Mizuho analyst Dan Dolev maintained Mastercard Inc (NYSE:MA) with a Buy, cut the price target from $435 to $375, maintained Visa Inc (NYSE:V) with a…

MA

Read More
1 minute read
  • Analyst Ratings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech
  • Trading Ideas

Here’s Why Accolade Shares Are Trading Higher Today

By Anusuya Lahiri
July 1, 12:49 PM
Needham analyst Ryan MacDonald reiterated a Buy rating on Accolade, Inc (NASDAQ:ACCD) with a price target of $12. Following a problematic 4QF22, he noted…

ACCD

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Price Target

HC Wainwright Sees Over 300% Upside In This Cancer-Focused Stock

By Vandana Singh
July 1, 12:48 PM
HC Wainwright has initiated Theseus Pharmaceuticals Inc (NASDAQ:THRX) with a Buy rating and a price target of $22 (310% upside). The analysts see…

THRX

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Government
  • Legal
  • News
  • Regulations
  • Small Cap
  • Top Stories
  • Trading Ideas

Supreme Court Ruling Dials Back EPA Powers: What It Means For Energy Stocks

By Wayne Duggan
July 1, 12:32 PM
The U.S. Supreme Court continued its busy summer this week, issuing a landmark ruling limiting the mpower of the Environmental Protection Agency. The ruling could have significant financial implications for a number of energy sector stocks.

AMR

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Guidance
  • Health Care
  • News
  • Price Target
  • Reiteration

Raymond James Thinks Haemonetics Growth Is ‘Underappreciated’

By Vandana Singh
July 1, 12:20 PM
Earlier this week, Raymond James attended Haemonetics Corp’s (NYSE:HAE) Investor Day, where the management team presented a new Long-Range Plan (LRP), including…

HAE

Read More
1 minute read
  • Analyst Ratings

Where Martin Marietta Materials Stands With Analysts

By Benzinga Insights
July 1, 12:12 PM
Analysts have provided the following ratings for Martin Marietta Materials (NYSE:MLM) within the last quarter:

MLM

Posts pagination

Previous 1 … 4,406 4,407 4,408 … 4,420 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service